Chemours annual operating income
2013
2014
2015
2022
2023
2024
2025
Chemours Operating Income Growth & History (CC)
Chemours's operating income was −$28.0M for fiscal 2025.
View full Chemours company overviewChemours annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$28.0M | −$449.0M | — |
| 2024 | 2024-12-31 | $421.0M | $544.0M | — |
| 2023 | 2023-12-31 | −$123.0M | −$909.0M | — |
| 2022 | 2022-12-31 | $786.0M | — | — |
| 2015 | 2015-12-31 | $4.63B | −$953.0M | −17.07% |
| 2014 | 2014-12-31 | $5.58B | −$342.0M | −5.77% |
| 2013 | 2013-12-31 | $5.92B | — | — |
Chemours quarterly operating income
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$210.0M | −$36.0M | — |
| Q1 2026 | 2026-03-31 | $39.0M | — | — |
| Q4 2025 | 2025-12-31 | −$5.0M | — | — |
| Q3 2025 | 2025-09-30 | $93.0M | — | — |
| Q2 2025 | 2025-06-30 | −$174.0M | — | — |
| Q3 2016 | 2016-09-30 | $1.17B | $69.0M | +6.26% |
| Q2 2016 | 2016-06-30 | $1.13B | −$138.0M | −10.93% |
| Q1 2016 | 2016-03-31 | $1.12B | −$49.0M | −4.18% |
| Q4 2015 | 2015-12-31 | $1.09B | — | — |
| Q3 2015 | 2015-09-30 | $1.10B | −$322.0M | −22.61% |
| Q2 2015 | 2015-06-30 | $1.26B | −$178.0M | −12.35% |
| Q1 2015 | 2015-03-31 | $1.17B | — | — |
| Q3 2014 | 2014-09-30 | $1.42B | — | — |
| Q2 2014 | 2014-06-30 | $1.44B | — | — |
Chemours operating income trends
Between the periods ended 2013-12-31 and 2025-12-31, Chemours's operating income decreased from $5.92B to −$28.0M, a change of −$5.95B. The latest reported quarter, Q2 2026, shows −$210.0M.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...